High Prevalence of Germline DNA-Repair Defects (DRD) in Advanced Cancer Patients Detected Through Precision Medicine Program

被引：0
|
作者：
Sailer, Verena [1 ]
Zhang, Tuo [1 ]
Mosquera, Juan Miguel [1 ]
Pisapia, David J. [1 ]
Pauli, Chantal [1 ]
Robinson, Brian [1 ]
Rao, Rema A. [1 ]
Cyrta, Joanna [1 ]
Kim, Rob [1 ]
McNarty, Terra J. [1 ]
Schiffman, Marc H. [1 ]
Nanus, David M. [1 ]
Tagawa, Scott T. [1 ]
Sboner, Andrea [1 ]
Elemento, Olivier [1 ]
Beltran, Himisha [1 ]
Rubin, Mark A. [1 ]
机构：
[1] Weill Cornell Med, New York, NY USA
来源：
MODERN PATHOLOGY | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1857
引用
收藏
页码：462A / 462A
页数：1
相关论文
共 43 条
  • [21] Germline DNA Damage Repair Variants and Prognosis of Patients with High-Risk or Metastatic Prostate Cancer
    Stopsack, Konrad H.
    Vijai, Joseph
    Conry, Michael
    Berchuck, Jacob E.
    Kemel, Yelena
    Vasselman, Samantha E.
    Freeman, Dory A.
    Lee, Gwo-Shu M.
    Mandelker, Diana
    Solit, David B.
    Morris, Michael J.
    Penney, Kathryn L.
    Abida, Wassim
    Offit, Kenneth
    Mucci, Lorelei A.
    Kantoff, Philip W.
    Pomerantz, Mark M.
    CLINICAL CANCER RESEARCH, 2025, 31 (01) : 122 - 129
  • [22] Pre-specified interim analysis of GALAHAD: A phase II study of niraparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and biallelic DNA-repair gene defects (DRD)
    Smith, M. R.
    Sandhu, S. K.
    Kelly, W. K.
    Scher, H. I.
    Efstathiou, E.
    Lara, N.
    Yu, E. Y.
    George, D. J.
    Chi, K. N.
    Saad, F.
    Summa, J.
    Freedman, J. M.
    Mason, G. E.
    Zhu, E.
    Ricci, D.
    Simon, J. S.
    Cheng, S.
    Fizazi, K.
    ANNALS OF ONCOLOGY, 2019, 30 : 884 - +
  • [23] Rare Germline Variants in DNA Repair Genes Detected in BRCA-Negative Finnish Patients with Early-Onset Breast Cancer
    Kurkilahti, Viivi
    Rathinakannan, Venkat Subramaniam
    Nynaes, Erja
    Goel, Neha
    Aittomaeki, Kristiina
    Nevanlinna, Heli
    Fey, Vidal
    Kankuri-Tammilehto, Minna
    Schleutker, Johanna
    CANCERS, 2024, 16 (17)
  • [24] Prevalence of incidental actionable germline mutations in 1,000 advanced cancer patients on a prospective somatic genomic profiling program
    Meric-Bernstam, Funda
    Brusco, Lauren
    Daniels, Molly S.
    Strong, Louise C.
    Shaw, Kenna Rael
    Lu, Karen H.
    Qi, Yuan
    Lara-Guerra, Humberto
    Litton, Jennifer Keating
    Zhao, Hao
    Eterovic, Agda Karina
    Arun, Banu
    Routbort, Mark
    Janku, Filip
    Davies, Michael A.
    Kopetz, Scott
    Mendelsohn, John
    Mills, Gordon B.
    Chen, Ken
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [25] Germline-focused analysis of tumour-detected variants in 49,264 cancer patients: ESMO Precision Medicine Working Group recommendations
    Kuzbari, Z.
    Bandlamudi, C.
    Loveday, C.
    Garrett, A.
    Mehine, M.
    George, A.
    Hanson, H.
    Snape, K.
    Kulkarni, A.
    Allen, S.
    Jezdic, S.
    Ferrandino, R.
    Westphalen, C. B.
    Castro, E.
    Rodon, J.
    Mateo, J.
    Burghel, G. J.
    Berger, M. F.
    Mandelker, D.
    Turnbull, C.
    ANNALS OF ONCOLOGY, 2023, 34 (03) : 215 - 227
  • [26] EFFECT OF GERMLINE POLYMORPHISMS OF DNA REPAIR GENES ON CHEMOTHERAPY OUTCOME IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
    Sullivan, I. G.
    Majem Tarruella, M.
    Paez, D.
    Pallares, C.
    Pare, L.
    Del Rio, E.
    Lopez Pousa, A.
    Barnadas, A.
    Ramon Y Cajal, T.
    Baiget, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 408 - 408
  • [27] Precision therapeutic targeting of DNA damage repair defects in ovarian cancer through molecular profiling of patient-derived tumor organoids.
    Hill, Sarah J.
    Horowitz, Neil S.
    Muto, Michael G.
    Worley, Michael J.
    Feltmate, Colleen M.
    Nucci, Marisa R.
    Sambel, Larissa A.
    Morizane, Ryuji
    Do, Khanh T.
    Kochupurakkal, Bose
    Bonventre, Joseph V.
    Matulonis, Ursula A.
    Shapiro, Geoffrey I.
    Berkowitz, Ross S.
    Crum, Christopher P.
    D'Andrea, Alan D.
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 67 - 68
  • [28] A phase II study of olaparib (AZD2281) in patients (Pts) with metastatic/advanced urothelial carcinoma and other genitourinary (GU) tumors with DNA-repair defects.
    Chandran, Elias
    Simon, Nicholas I.
    Niglio, Scot Anthony
    Ley, Lisa
    Cordes, Lisa M.
    Banday, Rouf
    Kesserwan, Chimene
    Mouw, Kent William
    Kydd, Andre Rashad
    Boudjadi, Salah
    Prokunina-Olsson, Ludmila
    Parikh, Mamta
    Flaig, Thomas W.
    Mckay, Rana R.
    Rezazadeh, Arash
    Ivy, S. Percy
    Iannantuono, Giovanni Maria
    Atiq, Saad Omar
    Steinberg, Seth M.
    Apolo, Andrea B.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [29] High Prevalence of Alterations in DNA Mismatch Repair Genes of Lynch Syndrome in Pediatric Patients with Adrenocortical Tumors Carrying a Germline Mutation on TP53
    Brondani, Vania Balderrama
    Montenegro, Luciana
    Ferreira Lacombe, Amanda Meneses
    Magalhaes, Breno Marchiori
    Nishi, Mirian Yumie
    de Assis Funari, Mariana Ferreira
    Narcizo, Amanda de Moraes
    Cardoso, Lais Cavalca
    Coelho Siqueira, Sheila Aparecida
    Nogueira Zerbini, Maria Claudia
    Denes, Francisco Tibor
    Latronico, Ana Claudia
    Mendonca, Berenice Bilharinho
    Almeida, Madson Queiroz
    Lerario, Antonio Marcondes
    Soares, Ibere Cauduro
    Barisson Villares Fragoso, Maria Candida
    CANCERS, 2020, 12 (03)
  • [30] Reversion of BRCA1/2 Germline Mutations Detected in Circulating Tumor DNA From Patients With High-Grade Serous Ovarian Cancer
    Christie, Elizabeth L.
    Fereday, Sian
    Doig, Ken
    Pattnaik, Swetansu
    Dawson, Sarah-Jane
    Bowtell, David D. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (12) : 1274 - 1280
12345